Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 10403170)

1.

Signaling pathways involved in thyroid hyperfunction and growth in Graves' disease.

Di Cerbo A, Corda D.

Biochimie. 1999 May;81(5):415-24. Review.

PMID:
10403170
2.

Autoimmunity: a new mechanism underlying thyroid autoimmunity revealed.

Greenhill C.

Nat Rev Endocrinol. 2014 Nov;10(11):639. doi: 10.1038/nrendo.2014.157. Epub 2014 Sep 2. No abstract available.

PMID:
25178731
3.

Sinonasal abnormalities in patients with Graves' orbitopathy.

Soler ZM, Platt MP, Leung MK, Mong S, Metson R.

Laryngoscope. 2011 Mar;121(3):656-60. doi: 10.1002/lary.21392. Epub 2010 Nov 18.

PMID:
21344449
4.

Application of new therapies in Graves' disease and thyroid-associated ophthalmopathy: animal models and translation to human clinical trials.

Banga JP, Nielsen CH, Gilbert JA, El Fassi D, Hegedus L.

Thyroid. 2008 Sep;18(9):973-81. doi: 10.1089/thy.2007.0406. Review.

PMID:
18752425
5.

TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.

Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Tørring O.

Eur J Endocrinol. 2008 Jan;158(1):69-75. doi: 10.1530/EJE-07-0450.

6.

The thyrotropin receptor in Graves' disease.

Rapoport B, McLachlan SM.

Thyroid. 2007 Oct;17(10):911-22. Review.

PMID:
17822379
7.

Graves' animal models of Graves' hyperthyroidism.

Nagayama Y.

Thyroid. 2007 Oct;17(10):981-8. Review.

PMID:
17822377
9.

Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay.

Hovens GC, Heemstra KA, Buiting AM, Stokkel MP, Karperien M, Ballieux BE, Pereira AM, Romijn JA, Smit JW.

Nucl Med Commun. 2007 Feb;28(2):123-7.

PMID:
17198353
10.

[Thyrotropin receptor--structure, autoantibody and signal transduction].

Endo T.

Nihon Rinsho. 2006 Dec;64(12):2203-7. Review. Japanese.

PMID:
17154079
11.

Estimation of serum TSH receptor autoantibody concentration and affinity.

Nakatake N, Sanders J, Richards T, Burne P, Barrett C, Pra CD, Presotto F, Betterle C, Furmaniak J, Smith BR.

Thyroid. 2006 Nov;16(11):1077-84.

PMID:
17123333
13.
14.
15.

[Diagnosis of autoimmune thyroid disease].

Trbojević B, Djurica S.

Srp Arh Celok Lek. 2005 Oct;133 Suppl 1:25-33. Review. Serbian.

PMID:
16405253
16.

Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease.

Shibayama K, Ohyama Y, Yokota Y, Ohtsu S, Takubo N, Matsuura N.

Endocr J. 2005 Oct;52(5):505-10.

17.

[Mouse model of Graves' disease].

Nagayama Y.

Nihon Rinsho. 2005 Oct;63 Suppl 10:62-5. Review. Japanese. No abstract available.

PMID:
16279604
18.

Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.

Mizutori Y, Saitoh O, Eguchi K, Nagayama Y.

J Autoimmun. 2006 Feb;26(1):32-6. Epub 2005 Oct 18.

PMID:
16242303
19.

[Relationship between OX40/4-1 BB (CD134/CD137) costimulatory molecules expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease].

Bossowski A, Stasiak-Barmuta A, Urban M, Rinderle C.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(3):133-40. Polish.

PMID:
16232366
20.

Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.

Quadbeck B, Hoermann R, Roggenbuck U, Hahn S, Mann K, Janssen OE; Basedow Study Group.

Thyroid. 2005 Sep;15(9):1047-54.

PMID:
16187913
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk